StockWatch
·
Other Pharmaceuticals
Corporate ActionMay 11, 2026, 08:07 AM

Synergy CHC Secures $36M Equity Line of Credit

AI Summary

Synergy CHC Corp. entered into an equity purchase agreement with Hudson Global Ventures, LLC, granting the company the right to sell up to $36,000,000 of its common stock over a 24-month period. This agreement provides financial flexibility, allowing the company to direct the investor to purchase shares under specific conditions and pricing mechanisms. As consideration, Synergy CHC issued a warrant for 1,540,000 shares to the investor and agreed to cover $20,000 in legal expenses. The company also committed to filing a registration statement to facilitate the resale of these shares by the investor.

Key Highlights

  • Synergy CHC secured an equity purchase agreement for up to $36,000,000 of common stock.
  • The agreement allows the company to sell shares over a 24-month period at its discretion.
  • Each purchase must be between $25,000 and $2,500,000, or 200% of 3-day average daily trading volume.
  • The purchase price for shares will be 95% of certain market prices.
  • The company issued a warrant for 1,540,000 common shares at $0.01 exercise price to the investor.
  • Synergy CHC will pay $20,000 for the investor's legal counsel expenses.
  • The investor's beneficial ownership is limited to 4.99% of outstanding common stock.
  • The company will file a registration statement within 30 days for the resale of shares.